Merck Wins New Jersey Vioxx Case

Law360, New York (July 13, 2006, 12:00 AM EDT) -- In a major victory for Merck & Co. that could save the company millions in future litigation, a New Jersey jury ruled in favor of the pharmaceutical company in the seventh Vioxx case to go to trial.

The jury deliberated for nearly 10 hours over the course of two days over whether Vioxx was a substantial factor in Elaine Doherty’s heart attack, and whether or not the company properly warned her of the risks of taking the drug.

The seven-person jury decided that Merck warned the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.